Template:Isosorbide dinitrate: Difference between revisions

Latest revision as of 15:00, 31 January 2014

Isosorbide dinitrate
ISORDIL^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Description
Clinical Pharmacology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

@@ Line 21: / Line 21: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Isosorbide dinitrate clinical pharmacology|Clinical Pharmacology]]
+|-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Isosorbide dinitrate clinical studies|Clinical Studies]]
 |-